Table 3.
Outcome | Time Period | Level of Evidence Rating (Human/Animal) | NTP Final Hazard Conclusion |
---|---|---|---|
Cholinesterase | Initial | High/Moderate | Known |
Intermediate | Low/Moderate | Suspected | |
Extended | Inadequate/Inadequate | Not Classifiable | |
Vision & Ocular Effects | Initial | Moderate/Inadequate | Suspected |
Intermediate | Moderate/Inadequate | Suspected | |
Extended | Low/Inadequate | Not Classifiable | |
Learning, Memory, & Intelligence | Initial | Inadequate/Low | Not Classifiable |
Intermediate | Low/Low | Not Classifiable | |
Extended | Moderate/Low | Suspected | |
Morphological & Histological Effects | Initial | Inadequate/Moderate | Suspected |
Intermediate | Inadequate/Moderate | Suspected | |
Extended | Moderate/Inadequate | Suspected |